Moderna
MRNA
$1.46 (-5.71%)
1D
1W
3M
1Y
5Y
ALL
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of Read More...Read Less
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Schaeffers Research • 1 day ago • MRNA
Cautious? Risky? Our Volatility Scorecard Can HelpWSJ • 2 days ago • MRNA
Why Moderna Merged Its Tech and HR DepartmentsAccesswire • 6 days ago • MRNA
Moderna to Present at Upcoming Bernstein's 41st Annual Strategic Decisions Conference (SDC) on May 29, 2025CNBC Television • 7 days ago • MRNA
New vaccine chief rocks pharmaceutical stocksZacks Investment Research • 8 days ago • MRNA
Moderna Sharpens Pipeline Focus as COVID-19 Vaccine Demand Ebbs in Q1Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.